Advanced Search
Latest accepted have been peer-reviewed and accepted, which are not yet assigned to volumes /issues, but are citable by Digital Object Identifier (DOI).
Current Status and Prospects of Stratified Diagnosis in Multiple Myeloma
Jian HOU
DOI: 10.3971/j.issn.1000-8578.2026.25.0725
Abstract PDF
Macrophage Lipid Metabolism: A Metabolic Hub in the Tumor Microenvironment and Novel Therapeutic Target, from Mechanistic Insights to Clinical Translation
Yu-xuan LI, Yun-hui LI, Qiao CHEN, Wei-jin SHEN, Huan REN
DOI: 10.3971/j.issn.1000-8578.2026.25.0569
Abstract PDF
The Future Landscape of Thymoma Diagnosis and Treatment: The Integrated Application of Multidisciplinary Collaboration and Emerging Technologies
Ye-hong LI, Hui Tian
DOI: 10.3971/j.issn.1000-8578.2026.25.0663
Abstract PDF
Diagnostic treatment and challenges of combined invasive fungal infections after chemotherapy for hematological neoplasms in children
Zhi GUO
DOI: 10.3971/j.issn.1000-8578.2025.25.0766
Abstract PDF
Parotid Carcinoma with Gastric Metastasis: An Analysis of a Clinical Case
Lin-lin HOU, Tian-yu GAO, Shi-bo LIAN, yong fan
DOI: 10.3971/j.issn.1000-8578.2026.25.0557
Abstract PDF
LIPG expression in ovarian cancer is associated with platinum resistance and prognosis
Chen QIN, Pei-yuan QIU, Qian-han DENG, Li LI
DOI: 10.3971/j.issn.1000-8578.2026.25.0430
Abstract PDF
Advances In The Pathophysiological Research Of Venetoclax And TumorLysis Syndrome
Hui-min ZHU, Zhi-yong CHENG, zhao zhang, yan li, Yuan DU, Hong-ning LI
DOI: 10.3971/j.issn.1000-8578.2026.25.0608
Abstract PDF
The role of targeted near-infrared fluorescent probes in tumors
Yu-lan SHEN, Hu-nan YE, Huan-huan ZHOU, Sai-ying MA, Jia-ying LI, Jia WANG, Xiao-jia WANG
DOI: 10.3971/j.issn.1000-8578.2026.25.0604
Abstract PDF
Pathological Characteristics of Hotspot Mutations in PIK3CA and TP53 Genes in Breast Cancer Cases from Qinghai Province
LI Xueyue, HU Jing, LIAO Hongyuan, ZHANG Haiqin, LI Xiude, LEI Hao, ZHOU Xiaofeng
DOI: 10.3971/j.issn.1000-8578.2025.25.0420
Abstract PDF
More+
More+
Chinese Expert Consensus on Oncology Multimorbidity Management (2025 Edition)
Chinese Society of Clinical Oncology (CSCO) Committee of Experts on Cancer Supportive and Rehabilitation Therapy
2025, 52(11): 879-912. DOI: 10.3971/j.issn.1000-8578.2025.25.0771
Abstract PDF
Developing Effective Strategies to Overcome Immunotherapy Resistance in Non-Small Cell Lung Cancer by Directly Targeting Cancer Cells
HUANG Qing, XIAO Jiaqi, HU Sheng, CAI Qian
2025, 52(11): 913-925. DOI: 10.3971/j.issn.1000-8578.2025.25.0508
Abstract PDF
Strategies to Overcome Immunotherapy Resistance in Non-Small Cell Lung Cancer: Targeting Non-Cancer Cells
CHEN Runzhi, XUE Chang, LI Xiaoyu, LI Yuanxiang, HU Sheng
2025, 52(11): 926-936. DOI: 10.3971/j.issn.1000-8578.2025.25.0506
Abstract PDF
Resistance to Immunotherapy in Non-Small Cell Lung Cancer: Intricate Mechanisms
WU Jingyi, ZHANG Xiaoyan, HU Sheng, ZHONG Yi
2025, 52(11): 937-944. DOI: 10.3971/j.issn.1000-8578.2025.25.0507
Abstract PDF
Clinical Effects of Intercostal Nerve Block Analgesia and Patient Controlled Intravenous Analgesia in Enhanced Recovery After Minimally Invasive Surgery for Lung Cancer: A Prospective Randomized Controlled Trial
ZHAO Ziyi, YE Yun, CHEN Xi, TIAN Long, ZHENG Xi, CHE Guowei
2025, 52(11): 945-950. DOI: 10.3971/j.issn.1000-8578.2025.25.0278
Abstract PDF
From Immune Microenvironment to Targeted Precision Therapy: New Strategies for Treatment of Pancreatic Cancer
YU Haiyan, ZHANG Huojun
2025, 52(11): 951-958. DOI: 10.3971/j.issn.1000-8578.2025.25.0358
Abstract PDF
More+

Special Issues

More+

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：